Company Analysis

Procter & Gamble Company (PG)

NYSE: PG · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Cincinnati, OH · filing with the SEC since 1994
Grade7.0
◀ Past 7.4● Present 6.9▶ Future 6.7

The company now

Procter & Gamble reported on 22 October 2026 that net sales for the first quarter of its fiscal 2027, the three months to September, rose 4 percent to $23.3 billion 1. Organic sales, which leave out currency moves and deals, also rose 4 percent, helped by 2.4 percent more units sold 1.

Profit barely moved: net earnings were $4.8 billion, the same as a year earlier, because costs rose as fast as sales 1. The gross margin, the share of sales left after production costs, fell 160 basis points, driven by 140 basis points of higher commodity costs and 140 of spending to improve products 1.

Shailesh Jejurikar, chief executive since 1 January 2026, credited "sharpened execution" of the company's strategy 15. The company now expects about $1.4 billion after tax of higher raw material, energy and transport costs this fiscal year, up from about $1 billion when it first guided in July 14.

On 1 October the company closed its purchase of Thorne, a maker of premium supplements, for $3.9 billion in cash 2. To help pay for it, it sold €3.25 billion of euro notes on 27 October alongside $4.0 billion (computed) of dollar notes 16. Thorne's results first appear in the quarter to 31 December 2026, the next test of whether the deal adds growth 2.

As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.

Where the revenue comes from

No split of its revenue is on file yet.

The desk's written account, in full. As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed. Nothing here is advice.

Past

William Procter and James Gamble founded the business in Cincinnati in 1837, and the company was incorporated in Ohio in 1905 3. It has paid a dividend for 136 years in a row since 1890 and raised it for 70 consecutive years 9.

Ten years ago the company shrank on purpose, keeping the brands where it led its markets 10. It handed Duracell batteries to Berkshire Hathaway in February 2016 and 41 beauty brands, among them salon hair care, cosmetics and most fine fragrances, to Coty on 1 October 2016 10. By fiscal 2017 about 100 brands were gone, leaving about 65 in 10 categories, and net sales were flat at $65.1 billion 10.

In fiscal 2019 it bought the over-the-counter medicines business of Merck KGaA for about $3.7 billion, a business selling mainly in Europe, Latin America and Asia 11. That year net sales rose 1 percent to $67.7 billion 11. It also wrote down Gillette shaving by $8.3 billion, citing weak currencies, men shaving less in rich countries and tougher competition 11.

The pandemic then raised demand for laundry, home cleaning and hygiene products, mainly in North America 12. In fiscal 2021 net sales rose 7 percent to $76.1 billion on 3 percent more units, led by double-digit gains in Health Care and in Fabric and Home Care 12.

When inflation followed, the company leaned on higher prices 13. In fiscal 2023 pricing added 9 percent to sales while units fell 3 percent and a strong dollar took away 5 percent, leaving net sales up 2 percent at $82.0 billion 13.

Fiscal 2024 brought two large charges 3. The company largely wound up its Argentina business, booking $1.2 billion after tax under that restructuring, and wrote Gillette down again by $1.3 billion before tax 3.

Sales then stalled near $84 billion, at $84.0 billion in fiscal 2024 and $84.3 billion in fiscal 2025 3. In fiscal 2026 they rose 3 percent to $87.0 billion, almost all from currency and pricing, with units flat 3. Operating income fell 3 percent to $19.7 billion as marketing spending rose and sales shifted toward lower-margin products 3.

Fiscal 2026 also carried $903 million after tax of charges under the new restructuring plan and a $261 million after-tax gain when the Glad venture with Clorox was dissolved 3. Cash left after capital spending, adjusted for one tax payment, equaled 100 percent of net earnings, against 87 percent in fiscal 2025 3.

The leadership turned over as well 56. Jon Moeller handed the chief executive's job to Jejurikar, then chief operating officer, on 1 January 2026, and left the board on 31 July 2026 after 38 years at the company 56.

Present

Fabric and Home Care

The biggest segment makes laundry and cleaning products: Tide, Ariel, Gain and Downy for clothes, and Cascade, Dawn, Fairy, Febreze, Mr. Clean and Swiffer for the home 3. In fiscal 2026 it sold $30.3 billion, 35 percent of the segments' sales, and earned $5.6 billion, 4 percent less, as commodity costs and mix squeezed margins 3. The company puts its share at over 35 percent of the fabric care markets it competes in and above 30 percent in home care 3.

In the first quarter of fiscal 2027 the segment's organic sales grew 4.8 percent, on more units sold in North America and Europe 1. Tide has begun a national rollout of Tide evo, a dry tile of woven cleaning fibers that dissolves in cold water and took about a decade to develop 20. Fortune put a box of 42 tiles at $19.99 on Amazon, against $12.97 for 42 Tide pods, which launched in 2012 and became a $2 billion a year business 20.

Baby, Feminine and Family Care

This segment sells Pampers and Luvs diapers and wipes, Always and Tampax period products, Always Discreet for incontinence, and Bounty, Charmin and Puffs paper 3. In fiscal 2026 it sold $20.4 billion, 24 percent of the segments' sales, and earned $3.9 billion 3. It holds more than 30 percent of the world's baby care market and nearly 30 percent of feminine care 3.

In North America, Bounty has nearly 40 percent of paper towels and Charmin over 25 percent of toilet paper 3. Yet paper was the weak spot, with Family Care sales down on promotions and competition and its North American share 0.7 points lower 3. Baby care went the other way in Greater China, where organic sales rose 20 percent on new products 3.

Beauty

Beauty covers hair care (Head & Shoulders, Pantene, Herbal Essences, Rejoice), personal care (Old Spice, Native, Secret, Safeguard) and skin care (Olay, SK-II) 3. Its sales rose 7 percent to $16.0 billion in fiscal 2026 on 4 percent more units, but earnings slipped 2 percent to $2.7 billion as marketing rose 3. The company puts its hair care and personal care shares at about 20 percent each worldwide and Olay at about 5 percent of facial skin care 3.

Skin care is losing ground: its global share fell 0.6 points in the first quarter of fiscal 2027, after a fall in Greater China the year before 73.

Health Care

Health Care is Crest and Oral-B for teeth, plus Vicks, Metamucil, Pepto-Bismol and Neurobion medicines and supplements 3. In fiscal 2026 it sold $12.5 billion and earned $2.4 billion, and the company counts nearly 30 percent of the world oral care market 3. Oral care is under pressure: sales fell in Greater China that year, and global share dropped 0.6 points in the first quarter of fiscal 2027 37.

The flagship Oral-B iO Series 10 brush has a suggested price of $350 22. TechRadar's Luke Edwards called it "high-priced but super-premium" with "dentist-level" cleaning, and Trusted Reviews called it "one of the best toothbrushes that money can buy" for an unlimited budget 2223. Live Science named the Philips Sonicare 9900 Prestige as a rival that cleans about as well 21.

Thorne joined the Personal Health Care business on 1 October 2026 and sells mainly in North America 2. Citing CNBC, NutraIngredients reported that Thorne passed $500 million of revenue in 2025 and that about 60 percent comes from buyers under 40 17. Mass Market Retailers reported that its supplements are used by more than seven million consumers and more than 100 professional sports teams 19.

Grooming

Grooming is Gillette and Venus razors and Braun shavers and hair-removal devices 3. In fiscal 2026 it sold $6.9 billion and earned $1.5 billion, with more than 60 percent of the world's blades and razors and nearly 30 percent of men's electric shavers 3. In the first quarter of fiscal 2027 its organic sales grew 4.5 percent, mostly on higher prices 1.

Plants and people

The company owns and runs 24 plants in 18 U.S. states and 72 in 31 other countries, and owns its Cincinnati headquarters 3. It had about 104,000 employees on 30 June 2026, 4 percent fewer than a year before because of restructuring 3. Of them, 49 percent work in manufacturing and 28 percent in the United States 3.

Jejurikar, who joined in 1989, has also chaired the board since 1 August 2026 6. Andre Schulten is the finance chief, and five sector chief executives run the businesses, among them Paul Gama at Health Care, who followed Jennifer Davis after her planned retirement on 30 June 2026 325. At the annual meeting on 13 October 2026, shareholders re-elected the board and voted down three shareholder proposals 8.

Customers and rivals

Walmart and its affiliates bought about 16 percent of sales, and the ten largest customers about 43 percent 3. Rivals range from global brands to retailers' own private labels, across price tiers from value to super-premium 3. Consumer health is consolidating: Kimberly-Clark agreed on 2 November 2025 to buy Kenvue, the maker of Tylenol and Listerine, and Kenvue said in August it aimed to close in the fourth quarter 24.

Problems on file

The company paid about $200 million of tariffs that the Supreme Court ruled invalid on 20 February 2026, and by June had booked half of it as recovered 3. In the United Kingdom, the Environment Agency intends a civil penalty of less than $2 million over a London plant's missing emissions permit, a matter still open 3. More than half of sales come from outside the United States, which exposes results to currency swings, and Russia was 1 percent of sales 3.

The umbrella, in words

The subsidiaries exhibit filed with the annual report names, among many others, The Gillette Company LLC, Braun GmbH in Germany, Tambrands Inc. and Gillette India Limited, all owned by the company 14. It also lists businesses bought in recent years, such as Mielle Organics, TULA Life, First Aid Beauty, Farmacy Beauty and New Chapter 14. The exhibit leaves out entities with very little activity, so it is not a full list 14.

The Glad joint venture with Clorox ended in January 2026, when Clorox bought out the company's minority stake for $476 million 3. The largest holder on file, Vanguard Capital Management, reported 7.52 percent of the common stock in a Schedule 13G dated 30 April 2026 15. Besides the common stock, the company has Series A and Series B ESOP convertible preferred shares, which received the same $1.0885 quarterly dividend declared in July 2026 9.

Future

On 22 October the company kept its fiscal 2027 forecast of 1 to 3 percent organic sales growth and raised its all-in sales growth range to 2 to 4 percent, to include Thorne 17. It expects 30 to 50 basis points of that growth to be lost to dropped brands, product forms and selling routes 1.

The company expects diluted earnings per share to grow 1 to 5 percent from $6.62 17. It expects core earnings per share, which leave out extra restructuring charges, to grow 0 to 3 percent from $6.89, a range of $6.89 to $7.11 17.

Costs weigh on that outlook: the company counts $1.4 billion after tax of commodity costs, $300 million of higher net interest and $150 million of lower non-operating income 1. With $50 million from currency, it puts the total at $0.79 a share 1.

It plans capital spending of 4.5 to 5.5 percent of sales and expects a core tax rate of 20 to 21 percent 71. It expects to pay over $10 billion of dividends and buy back about $5 billion of its shares in fiscal 2027 1.

Its standing long-term goals are organic sales growth above its markets, core earnings per share growth in the mid-to-high single digits, and free cash flow of 90 percent or more of net earnings 3.

Under the plan announced in June 2025, the company expects $1.5 to $2.0 billion of restructuring costs before tax over two years, the rest of them in fiscal 2027 3. The plan cuts up to 7,000 non-manufacturing jobs by the end of fiscal 2027 and includes brand and market exits 32.

The company plans to finish the accounting for Thorne's assets in the quarter to 31 December 2026, the first quarter that includes its results 2. The euro notes settle on 3 November 2026 and mature between 2030 and 2046, and the dollar notes were due to be issued on 30 October 16.

What it may be looking into

Speculation Speculation, labeled as such: where the clues point, how sure the desk is of each, and what would change it. It is not a forecast and not advice.

  1. Speculation

    P&G may buy more wellness and supplement brands to widen its health care business.

    Because

    • Thorne, bought for $3.9 billion in October 2026, is its second large health deal since the $3.7 billion purchase of Merck KGaA's medicines business in fiscal 2019 211.
    • Announcing the deal, Health Care chief Paul Gama said "consumer interest in self-care, prevention, wellness and personalized health continues to grow" 17.
    • Nutrition Insight placed the deal among similar purchases by large consumer companies, such as Unilever's deal for the supplement maker Grüns 18.
    Confidence 55 of 100What would change this A current report or release naming another vitamin, supplement or wellness purchase would confirm it; quarterly reports showing only debt repayment and buybacks for the coming year would weaken it 2.
  2. Speculation

    P&G may exit more brands and small markets before its restructuring plan ends.

    Because

    • The quarterly report says the plan announced in June 2025 includes brand and market exits 2.
    • The company's fiscal 2027 guidance already counts a drag of 30 to 50 basis points from discontinued brands, product forms and selling routes 1.
    • It has done this before: it largely wound up its Argentina business in 2024 and dropped about 100 brands by fiscal 2017 310.

    What it could addSI estimate Estimate: a drag of 30 to 50 basis points on fiscal 2026 net sales of $87.0 billion is about $261 million to $435 million of sales (computed), a rough size of exits already planned 13.

    Confidence 60 of 100What would change this A filing naming a market exit or a brand sale would confirm it; the plan closing in fiscal 2027 with no further exit named would refute it 3.
  3. Speculation

    P&G could take Thorne beyond North America through its own international business.

    Because

    • The quarterly report says Thorne sells mainly in North America, while the annual report says more than half of the company's sales come from outside the United States 23.
    • Gama said the company sees "an opportunity to bring Thorne's science-backed wellness solutions to more consumers" 18.
    • The Merck KGaA business it bought in fiscal 2019 sells mainly in Europe, Latin America and Asia, so the company already runs consumer health outside the United States 11.
    Confidence 45 of 100What would change this A results release or quarterly report naming Thorne launches in Europe or Asia would confirm it; Thorne still described as a North American brand in the next annual report would weaken it 2.

How the company works

The desk has not read this company's annual report yet.

The record in brief

five sections from the record

By the desk, an AI model (Claude Haiku 4.5), written from the company's record on Oct 22, 2026; nothing here is advice. Every sentence rests on the numbered source beside it, and a sentence the record did not support was cut before the report was kept.

A newer quarterly report (Form 10-Q, filed 2026-10-22) and current report (Form 8-K, filed 2026-11-03) is on file; this report was written before it, and the desk writes it again on request.

Past

Procter & Gamble's revenue grew from $65 billion in fiscal 2017 to $87 billion in fiscal 2026, up 3.3% a year, and rose in 9 of 9 years with no fall from a peak; net income was positive in 10 of 10 years. Over the three fiscal years to 2026-06-30, the diluted share count shrank about 0.8% a year, and dividends and buybacks returned about 80% of operating cash flow. Officers and directors filed 32 sales and 0 purchases of their own stock on the open market in the year to 2026-10-14. The grade's past tense reads 7.4 of 10. 12

Present

In its latest annual figures for the fiscal year ended 2026-06-30, Procter & Gamble reported revenue of $87 billion and a profit of $16 billion. The company earned about 30 cents of profit for every dollar of shareholders' money, and its products earned about 35 cents per dollar of everything it owns; it owed about 57 cents per dollar of assets, and its share count shrank 1.3% over the year. Procter & Gamble's revenue of $87 billion ranks in the top 4% by size among its family; a net margin of 18.4% ranks in the top 10%; revenue growth of 2% a year over the last three years ranks in the top 43%. The chief executive is Jejurikar, Shailesh, filing under that title since 2026-08-10 for 2 months; the 31 officers and directors have been on the record a median of 5.1 years; 8 officer or director changes were reported since 2023-10-21 against the 31 people in charge now. The grade's present tense reads 6.8 of 10. 21

Future

A quarterly report (Form 10-Q) for the quarter ending 2026-09-30 is due by 2026-11-09. An annual report (Form 10-K) for the fiscal year ending 2027-06-30 is due by 2027-08-29. The company's room to grow leaves cash of $9.9 billion against debt of $23 billion, or negative 10.2% of its assets; cash from operations less capital spending is 17.4% of revenue; a gross margin of 50.2%; research spending of 2.4% of revenue, ranking in the top quartile of its family. Revenue grew 2% a year over the last three filed years against 3.3% over all 10, slowing; the newest year grew 3.3%; research spending grew 1.6% a year; capital spending grew 12.9% a year; the company reported 5 lines of business in fiscal 2025, with Fabric Home Care at $30 billion and Baby Feminine Family Care at $20 billion as the largest lines, and 3 of 5 grew in the latest filed year. The grade's future tense reads 6.7 of 10. 312

How the company operates

Procter & Gamble is a product business classed under Soap, Detergents, Cleaning Preparations, Perfumes and Cosmetics. The company's revenue comes from five lines: Fabric Home Care (the largest, at roughly $30 billion in recent years), Baby Feminine Family Care (roughly $20 billion), Beauty (roughly $15 billion), Health Care (roughly $11 to $12 billion), and Grooming (roughly $6 to $7 billion). 24

New moves

On 2026-10-16, Form 8-K filed a shareholder vote result on Leadership and Shareholder treatment. On 2026-10-15, three shelf registrations filed, each a large filer's shelf ready for sale. On 2026-10-13, Form 8-K filed an investor disclosure under Regulation FD. On 2026-07-29, Form 8-K filed an officer or director change and an investor disclosure under Regulation FD. On 2026-09-28, a story by the desk named the event "U. S. and China '30-for-30' lists leave soybeans off"; Procter & Gamble is adjacent to the event, as the U. S. and China published tariff lists valued on 2024 trade. 35

Sources

a number beside a sentence opens its entry in its own document's list
The written account 25 sources · as of Oct 28, 2026
  1. Exhibit 99.1 to Form 8-K, P&G Announces Fiscal Year 2027 First Quarter Results ↗The Procter & Gamble Company (SEC filing) · filed Oct 22, 2026
  2. Form 10-Q, quarterly report for the quarter ended 30 September 2026 ↗The Procter & Gamble Company (SEC filing) · filed Oct 22, 2026
  3. Form 10-K, annual report for the fiscal year ended 30 June 2026 ↗The Procter & Gamble Company (SEC filing) · filed Aug 4, 2026
  4. Exhibit 99.1 to Form 8-K, P&G Announces Fourth Quarter and Fiscal Year 2026 Results ↗The Procter & Gamble Company (SEC filing) · filed Jul 29, 2026
  5. Exhibit 99.1 to Form 8-K, Shailesh Jejurikar Elected P&G President and Chief Executive Officer ↗The Procter & Gamble Company (SEC filing) · filed Jul 28, 2025
  6. Exhibit 99.1 to Form 8-K, Shailesh Jejurikar Appointed Chairman of P&G Board of Directors ↗The Procter & Gamble Company (SEC filing) · filed Jul 29, 2026
  7. Exhibit 99.1 to Form 8-K, earnings slides for the first quarter of fiscal 2027 ↗The Procter & Gamble Company (SEC filing) · filed Oct 22, 2026
  8. Form 8-K, voting results of the 2026 annual meeting of shareholders ↗The Procter & Gamble Company (SEC filing) · filed Oct 16, 2026
  9. Exhibit 99.1 to Form 8-K, P&G Declares Quarterly Dividend, July 2026 ↗The Procter & Gamble Company (SEC filing) · filed Jul 14, 2026
  10. Form 10-K, annual report for the fiscal year ended 30 June 2017 ↗The Procter & Gamble Company (SEC filing) · filed Aug 7, 2017
  11. Form 10-K, annual report for the fiscal year ended 30 June 2019 ↗The Procter & Gamble Company (SEC filing) · filed Aug 6, 2019
  12. Form 10-K, annual report for the fiscal year ended 30 June 2021 ↗The Procter & Gamble Company (SEC filing) · filed Aug 6, 2021
  13. Form 10-K, annual report for the fiscal year ended 30 June 2023 ↗The Procter & Gamble Company (SEC filing) · filed Aug 4, 2023
  14. Exhibit 21 to Form 10-K, Subsidiaries of the Registrant, as of 30 June 2026 ↗The Procter & Gamble Company (SEC filing) · filed Aug 4, 2026
  15. Schedule 13G on The Procter & Gamble Company common stock ↗Vanguard Capital Management (SEC filing) · filed Apr 30, 2026
  16. Free writing prospectus, pricing term sheet for EUR 3,250,000,000 of notes ↗The Procter & Gamble Company (SEC filing) · filed Oct 27, 2026
  17. P&G to acquire Thorne in premium wellness play ↗NutraIngredients (Cassandra Stern) · Aug 4, 2026
  18. P&G to acquire supplement company Thorne for US$3.8B to boost health portfolio ↗Nutrition Insight (Jolanda van Hal) · Aug 5, 2026
  19. Procter & Gamble posts first-quarter revenue and profit gains ↗Mass Market Retailers · Oct 22, 2026
  20. P&G thinks it's unlocked the future of the $25 billion laundry industry. Meet the Tide evo tile ↗Fortune (Matty Merritt, Morning Brew) · Feb 18, 2026
  21. Oral-B iO Series 10 review ↗Live Science (Luke Edwards) · Nov 2, 2022
  22. Oral-B iO Series 10 review ↗TechRadar (Luke Edwards) · Nov 1, 2022
  23. Oral-B iO Series 10 review ↗Trusted Reviews (Esat Dedezade) · Sep 22, 2023
  24. Exhibit 99.1 to Form 8-K, Kenvue Reports Second Quarter 2026 Results ↗Kenvue Inc. (SEC filing) · filed Aug 6, 2026
  25. Form 8-K, retirement notice of the Chief Executive Officer, Health Care ↗The Procter & Gamble Company (SEC filing) · filed Dec 15, 2025
The record in brief 5 sources · written Oct 22, 2026
  1. PG: the nine metricsthis site's record
    show the quoted wordsTrack record (past, graded 7.2 of 10, weighs 45% of the past): Procter & Gamble Company's 10 filed years say what it did: revenue went from $65 billion in fiscal 2017 to $87 billion in fiscal 2026, up 3.3% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 10 of 10 of those years (its annual reports).Shareholder treatment (past, graded 8.9 of 10, weighs 22% of the past): Over the 3 fiscal years to 2026-06-30, Procter & Gamble Company's diluted share count shrank about 0.8% a year, and dividends and buybacks returned about 80% of its operating cash flow over 3 years (its filed statements).Its officers and directors filed 32 sales and 0 purchases of their own stock on the open market in the year to 2026-10-14 (their Form 4 filings).Financial health (present, graded 7.1 of 10, weighs 45% of the present): Return on equity: in the fiscal year ended 2026-06-30, Procter & Gamble Company earned about 30 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 35 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 57 cents perIndustry position (present, graded 8.1 of 10, weighs 33% of the present): Procter & Gamble Company's standing among 15 graded names in its industry family: revenue of $87 billion in fiscal 2026 ranks in the top 4% by size; a net margin of 18.4% ranks in the top 10%; revenue growth of 2% a year over the last 3 filed years ranks in the top 43% (its annual reports).Leadership (present, graded 4.3 of 10, weighs 22% of the present): Procter & Gamble Company's leadership, from its insiders' filings and its current reports: the chief executive on the record is Jejurikar, Shailesh (Chairman, President and CEO, as filed), filing under that title since 2026-08-10, 2 months (bottom 13% of its family); the 31 officers and directors filing in the last fifteen months hRoom to expand (future, graded 8.1 of 10, weighs 45% of the future): Procter & Gamble Company's room to grow, from the newest filed statements (fiscal 2026): cash of $9.9 billion against debt of $23 billion leaves -10.2% of its assets as net cash, top 23% of its family; cash from operations less capital spending is 17.4% of revenue (top 17%); a gross margin of 50.2% (top 10%); research spending ofGrowth drivers (future, graded 5.7 of 10, weighs 33% of the future): Procter & Gamble Company's growth drivers, from the filed years to fiscal 2026: revenue grew 2% a year over the last three filed years against 3.3% over all 10, slowing (top 37% of its family); the newest year grew 3.3% (top 43%); research spending grew 1.6% a year (bottom 39%); capital spending grew 12.9% a year (top 30%) (its a
  2. PG: the company filethis site's record
    show the quoted wordsHeadline grade 6.9 of 10; the arc reads past 7.4, present 6.8, future 6.7; 9 of 9 metrics read as filed.In its latest annual figures on file, for the fiscal year ended 2026-06-30, it reported revenue of $87 billion and a profit of $16 billion (its filed statements).Product business (prior from its industry code (SEC 2840, Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics); the filing read can change it).
  3. PG: the filing record, ten yearsa filing
    show the quoted wordsDeadline ahead: Quarterly report (Form 10-Q) for the quarter ending 2026-09-30 is due by 2026-11-09; large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.Deadline ahead: Annual report (Form 10-K) for the fiscal year ending 2027-06-30 is due by 2027-08-29; large accelerated filers have 60 days after the fiscal year ends.2026-10-16: Form 8-K, Current report (Shareholder vote, item 5.07). Leadership and Shareholder treatment: the vote results.Document: https://www.sec.gov/Archives/edgar/data/80424/000008042426000245 2026-10-15: Form S-3ASR, Shelf registration. The filing record and the share count: a large filer's shelf, ready for sale. Document: https://www.sec.gov/Archives/edgar/data/80424/000008042426000243 2026-10-15: Form S-3ASR, Shelf registration. The filing record and the share count: a large filer's shelf, ready for sale. DocuDocument: https://www.sec.gov/Archives/edgar/data/80424/000008042426000239 2026-10-13: Form 8-K, Current report (Investor disclosure (Regulation FD), item 7.01). The news lane: a disclosure to investors under Regulation FD.Document: https://www.sec.gov/Archives/edgar/data/80424/000087666126000657 2026-07-29: Form 8-K, Current report (Investor disclosure (Regulation FD), item 7.01). The news lane: a disclosure to investors under Regulation FD. Document: https://www.sec.gov/Archives/edgar/data/80424/000008042426000097 2026-07-29: Form 8-K, Current report (Officer or director change, item 5.02; Investor disclosure (Reg
  4. PG: the money and the checks, as fileda filing
    show the quoted wordsRevenue by line of business, FY2023 (USD billions): Health Care 11.23; Baby Feminine Family Care 20.22; Beauty 15.01; Fabric Home Care 28.37; Grooming 6.42. Revenue by line of business, FY2024 (USD billions): Fabric Home Care 29.5; Baby Feminine Family Care 20.28; Health Care 11.79; Beauty 15.22; Grooming 6.65. Revenue by line of business, FY2025 (USD billions): Grooming 6.66; Health Care 12; Beau
  5. PG: the stories that name itthis site's record
    show the quoted words2026-09-28: "U.S. and China '30-for-30' lists leave soybeans off": The White House's terms of reference say the two lists were valued on 2024 trade and that any tariff cut 'will be determined and implemented in accordance with each side's domestic legal processes', with no date; China's commerce ministry, as the Associated Press reported it, said duties on more than nine in ten covered products wo
SI Assistanton PG · research, not advice